Lethal Infection by Bordetella Pertussis Mutants in the Infant Mouse Model
Overview
Authors
Affiliations
Different aspects of lethal infection of infant mice with Bordetella pertussis were examined. Mutants deficient in vir-regulated genes were tested for the ability to cause a lethal infection in the infant mouse model. Adenylate cyclase toxin-hemolysin and pertussis toxin were required to cause a lethal infection at low doses. Mixed infection caused by challenging the mice with an equal number of pertussis toxin and adenylate cyclase toxin-hemolysin mutants at a dose at which neither alone was lethal was also unable to cause a lethal infection. Production of the filamentous hemagglutinin and the dermonecrotic toxin was not required to cause a lethal infection. Nine other mutants in vir-regulated genes whose phenotypes have yet to be determined were also tested. Only two of these mutants were impaired in the ability to cause a lethal infection. Expression of fimbriae does not appear to affect the dose required to cause a lethal infection; however, fimbrial expression was correlated with the later stages of a nonlethal, persistent infection. Growth of the bacteria in MgSO4, a condition which reversibly suppresses expression of the genes required for virulence, did not alter the ability of the bacteria to cause a lethal infection. Auxotrophic mutants deficient in leucine biosynthesis were as virulent as the parental strain; however, mutants deficient in methionine biosynthesis were less virulent. A B. parapertussis strain was much less effective in promoting a lethal infection than any of the wild-type B. pertussis strains examined. A persistent infection in the lungs was observed for weeks after challenge for mice given a sublethal dose of B. pertussis, and transmission from infected infants to the mother was never observed.
Role of Major Toxin Virulence Factors in Pertussis Infection and Disease Pathogenesis.
Scanlon K, Skerry C, Carbonetti N Adv Exp Med Biol. 2019; 1183:35-51.
PMID: 31376138 PMC: 7038575. DOI: 10.1007/5584_2019_403.
Association of Pertussis Toxin with Severe Pertussis Disease.
Scanlon K, Skerry C, Carbonetti N Toxins (Basel). 2019; 11(7).
PMID: 31252532 PMC: 6669598. DOI: 10.3390/toxins11070373.
Bioengineering of Adenylate Cyclase Toxin for Antigen-Delivery and Immunotherapy.
Chenal A, Ladant D Toxins (Basel). 2018; 10(7).
PMID: 30037010 PMC: 6070788. DOI: 10.3390/toxins10070302.
cesnek M, Skacel J, Jansa P, Dracinsky M, Smidkova M, Mertlikova-Kaiserova H ChemMedChem. 2018; 13(17):1779-1796.
PMID: 29968968 PMC: 6415679. DOI: 10.1002/cmdc.201800332.
Revealing how an adenylate cyclase toxin uses bait and switch tactics in its activation.
Finley N PLoS Biol. 2018; 16(2):e2005356.
PMID: 29485992 PMC: 5844667. DOI: 10.1371/journal.pbio.2005356.